Benzinga | May 7, 2021 07:38AM EDT

SVB Leerink Maintains Outperform on Insulet, Lowers Price Target to $300

SVB Leerink analyst Danielle Antalffy maintains Insulet (NASDAQ:PODD) with a Outperform and lowers the price target from $320 to $300.